Show simple item record

dc.contributor.authorMrudula Phadke, Sujata Saunik
dc.description.abstractCorona virus disease (COVID-19) has created pandemic in the world as declared by WHO on March 12, 2020. It is a viral disease caused by SARS-CoV 2 virus and has affected large populations in over 120 countries. There is no specific treatment available and management is empirical. Until such time that an effective vaccine is available for COVID-19 viral infection, one can repurpose known therapeutic drug molecules such as angiotensin receptor 2 blocker, a commonly used antihypertensive drug, to control COVID-19 virus from gaining entry into the host cell by blocking the angiotensin receptor. Clinical trials should also be undertaken to use statins, which are lipid-lowering drugs but have anti-inflammatory and immunomodulatory properties to prevent acute lung injury in COVID-19 infection.en_US
dc.subjectInfectious Diseasesen_US
dc.subjectClinical Trialen_US
dc.subjectLung Diseasesen_US
dc.titleCOVID‐19 treatment by repurposing drugs until the vaccine is in sighten_US
eihealth.categoryCandidate therapeutics RDen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US
dc.relation.ispartofjournalDrug Development Researchen_US

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record